Login
$CMPX
$0.69 +$0.03 (4.07%) After hours

Ownership

13F as of Q2 2026 · 186.8M shares outstanding

Who owns CMPX?

By type of holder
Institutions 100.0% Insiders 0.0% Everyone else 0.0%
Concentration Top 10 holders own 81.3%
Gordon Carl L 16.9% · Tang Capital Management LLC 12.3%
Institutional ownership
100.0%
0 pts vs last qtr
Institutional holders
360
+45 vs last qtr
Net shares bought
−10.2M
by institutions in Q2 2026
New / sold out
102 / 57
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Palo Alto Investors LP +4.3M
  • Citadel Advisors LLC +3.6M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • BVF Inc/il SOLD OUT −7.8M
  • Adage Capital Partners GP, L.L.C. −7.3M

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Compass Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2019–FY2025
+3053.9%
+77.75% a year
Each share's claim on the business
−96.8%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $37.3M
over 7 fiscal years
Diluted shares, split-adjusted
4.9M82.1M159.3M2019: 5.0M shares'192020: 30.8M shares'202021: 62.9M shares'212022: 105.2M shares'222023: 127.0M shares'232024: 137.4M shares'242025: 157.7M shares'25
Buybacks Stock-based comp
$0$4.3M$8.6M2019 buybacks: $02019 stock comp: $915.0K'192020 buybacks: $02020 stock comp: $4.0M'202021 buybacks: $02021 stock comp: $4.0M'212022 buybacks: $02022 stock comp: $5.3M'222023 buybacks: $02023 stock comp: $6.1M'232024 buybacks: $02024 stock comp: $8.6M'242025 buybacks: $02025 stock comp: $8.4M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years5% 3–5 years34% 1–3 years35% Under 1 year25%
Quarterly turnover
23.8%
of institutional shares changed hands
Top 10 managers, median time held
1.8 years

Super Investors

Investment managers reporting CMPX on Form 13F
TC
Tang Capital Management LLC
Shares
23.0M
% of company
12.31%
Change vs last qtr
+2.2M (+10.6%)
Held since
2024
OA
Orbimed Advisors LLC
13D · 8.9%
Shares
15.2M
% of company
8.15%
Change vs last qtr
−1.2M (−7.0%)
Held since
2021

28 more super investors behind a free account

See every manager holding Compass Therapeutics, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting CMPX on Form N-PORT; together they hold 23.6% of the company
AG
Position value
$50.7M
% of company
2.39%
% of the fund
3.25%
As of
July 31, 2026
Position value
$15M
% of company
3.66%
% of the fund
0.14%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Compass Therapeutics, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
GC
Gordon Carl L
Insider
Shares
31.5M
% of company
16.87%
Change vs last qtr
—
Held since
—
OC
Orbimed Capital GP V LLC
5%+ holder13D · 8.9%
Shares
15.2M
% of company
8.15%
Change vs last qtr
—
Held since
—

7 more holders behind a free account

See every insider and 5%+ holder of Compass Therapeutics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support